This Week in Psychedelics - 2.25.22

Cannabis

  • Where Is The Cannabis Industry Headed In 2022? (Forbes)

  • The Media’s War on Cannabis (Volteface)

  • Michigan marijuana recall reversal let businesses sell contaminated cannabis (MLive.com)

  • Why you still can’t buy legal pot in N.J. 16 months after voters gave the go-ahead (The Philadelphia Inquirer)

  • Customers At South Dakota’s Only Medical Dispensary Still Getting Arrested (High Times)

  • The US cannabis industry now supports 428,059 jobs (Leafly)

  • Cannabis shown to be an effective treatment option for back pain: Study review (The GrowthOp)

  • New Law Could Help Free Louisiana Man Serving Life in Prison For Cannabis (High Times)

  • South Dakota Governor Won’t Rule Out Vetoing Marijuana Legalization Bill That Passed The Senate (Marijuana Moment)

  • New Zealand Police Reboot Illegal Cannabis Operation Search After Year of Inactivity (High Times)

  • Marijuana Legalization Bill Heads To Delaware House Floor Following Second Committee Approval (Marijuana Moment)

  • Oregon Lawmakers Take On State’s Illicit Pot Operations (High Times)

  • Maryland Lawmakers Vote To Put Marijuana Legalization Referendum On November Ballot (Marijuana Moment)

  • London drug trial a vital but ‘tiny’ step (Green World)

  • College Students Who Use Marijuana Show Signs Of Greater Motivation Compared To Non-Users, Study Finds (Marijuana Moment)

  • California Bill Would Protect Cannabis Users From Employment Discrimination (High Times)

  • Our outdated marijuana laws put Americans in danger. It's past time for federal cannabis reforms. (USA Today)

  • Three In Four Florida Voters Support Legalizing Marijuana, New Poll Finds (Marijuana Moment)

Magic Mushrooms

  • Psilocybe ovoideocystidiata: The Ohio Valley Shroom Taking Over the World (DoubleBlind)

  • Probing How Magic Mushrooms Might Help Cure Addiction (Discover)

  • Oregon Senators Approve Psilocybin Equity Bill In Committee (Marijuana Moment)

  • Oklahoma Lawmakers Pass Psilocybin Bill in Committee (Truffle Report)

  • Second Hawaii Senate Committee Approves Psilocybin Task Force Bill, With Decriminalization Measures Still Pending (Marijuana Moment)

  • Can ‘magic mushrooms’ make the trip to legal in conservative Utah? (The Salt Lake Tribune)

MDMA

  • MDMA Doesn't Actually Cause Comedowns, New Study Finds (VICE)

DMT

  • New study offers a detailed glimpse into the otherworldly encounters produced by the psychedelic drug DMT (PsyPost)

  • The First-Ever Clinical Trial For DMT Use In Major Depressive Disorder Show Promise (The Dales Report)

  • Tackling Trauma with Pharmahuasca and DMT (Psychedelic Science Review)

Mescaline

Iboga

  • Gabon Takes First Step Toward Legal Export of Sustainable Iboga (Lucid News)

Nitrous Oxide

Ketamine

  • N.B. clinic brings psychedelic drug to mainstream to treat PTSD (CBC)

Miscellaneous

  • The Insights Psychedelics Give You Aren’t Always True (VICE)

  • Your Brain on Psychedelics Might Look the Same as Your Brain on Religious Mysticism (DoubleBlind)

  • Top Federal Drug Agency Funds Research On Differing Legal Marijuana Regulatory Models (Marijuana Moment)

  • California’s Proposed Psychedelic Decrim Bill Paused in State Assembly (Lucid News)

  • The Corporatization of Psychedelics Would Be a Disaster (Jacobin)

  • Police Keep Arresting People For Drugs Even As Incarceration Rates Drop, Pew Study Finds (Marijuana Moment)

  • Reclaiming Ownership of Your Body With Psychedelics (Psychedelics Today)

  • At Harvard, Psychedelic Drugs' Tentative Renaissance (The Harvard Crimson)

  • Utah Senate Committee Approves Psychedelics Study Task Force Bill That Already Passed House (Marijuana Moment)

  • Is the Hype Around Psychedelics Bursting? (Psychology Today)

  • What’s Next for Australia’s Psychedelics Movement? (Truffle Report)

  • Why Victoria should review its response to drugs and decriminalise usage (The Age)

  • After Its Vilification In The 1960s, There Is Now A Renaissance In Psychedelic Drugs To Help Treat Depression And Mental Health Issues (Forbes)

  • Do Psychedelic Drug Therapies Actually Require Getting High? (Discover)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.